On December 11, Glonghui reported that Eli Lilly and Co's CEO Dave Ricks stated that the company will begin studying whether its best-selling weight loss drug can also effectively control addiction behaviors such as alcoholism, smoking, and drug use. Ricks mentioned in a meeting that these medications are 'antidotes to pleasure' and may temporarily free patients from dependence on drugs. Some doctors have already indicated that this drug can help alleviate drug addiction. Novo-Nordisk A/S also indicated earlier this year that it plans to research drug addiction.